Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Board Changes

6 May 2025 07:12

RNS Number : 4359H
Argentex Group PLC
06 May 2025
 

6 May 2025

 

Argentex Group plc

("Argentex" or the "Company")

 

Board Changes

 

Argentex Group PLC (AIM: AGFX) announces that, following the 25 April 2025 announcement regarding the recommended acquisition of Argentex by IFX Payments, the directors had reviewed the composition of the board and agreed that it would be in the best interests of the Company and its shareholders to reduce the number of directors. Accordingly, each of Henry Beckwith, Lord Digby Jones, Rina Ladva and Jeff Parker (all non-executive directors of the Company) agreed to resign and left the board on Friday 2 May 2025.

 

In addition, Guy Rudolph, the Company's Chief Financial Officer, on Friday 2 May 2025 notified the board of his resignation. Guy will continue to serve as Chief Financial Offer of the Company whilst he serves out his notice period of 6 months.

 

Following the completion of statutory Due Diligence checks, Tim Rudman was formally appointed to the board on 5 May 2025.

 

Following Tim's appointment the board now consists of Nigel Railton, non-executive chairman, Jonathan Gray, senior independent non-executive director, Tim Haldenby, independent non-executive director and Tim Rudman as Chief Executive Officer.

 

Nigel Railton, Chairman of Argentex said:

 

"Against the background of an extremely challenging past few weeks for Argentex, I would like to thank Henry, Lord Digby, Rina and Jeff for their expertise and contribution to Argentex during their tenure with the Company. Each of their experiences have provided valuable perspective for both the board and the wider group. We wish each of them well for the future."

 

For further information, please contact:

 

Argentex Group PLC

Tim Rudman - Interim Chief Executive Officer

investorrelations@argentex.com

 

Teneo (Financial PR)

James Macey-White/Victoria Boxall/ Riann Cato

argentex@teneo.com, 020 7260 2700

 

Singer Capital Markets (Financial Adviser, Nominated Adviser and Broker)

Tom Salvesen / James Maxwell / James Todd

020 7496 3000

 

Disclosure under Schedule 2(g) of the AIM Rules for Companies

 

Timothy James Rudman, aged 41, holds/has held the following directorships in the last five years:

 

Current Directorships / Partnerships

Previous Directorships / Partnerships

· N/A

· Foreign Currency Exchange Limited

· Global Reach Partners Limited

· Rudman Capital Ventures LTD

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKPBBDBKBPPK
Date   Source Headline
23rd Apr 202510:30 amRNSStatement regarding Argentex Group plc
23rd Apr 20259:48 amRNSForm 8.3 - Argentex Group plc
23rd Apr 20257:00 amRNSHolding(s) in Company
23rd Apr 20257:00 amRNSResponse to Media Speculation & Financial Position
22nd Apr 20257:40 amRNSSuspension - Argentex Group Plc
22nd Apr 20257:15 amRNSFinancial Position & Suspension of trading
15th Apr 202510:30 amRNSPublication of Annual Report and Notice of AGM
11th Apr 20254:35 pmRNSDirector/PDMR Shareholding
7th Apr 202510:21 amRNSDirector/PDMR Shareholding
4th Apr 20259:31 amRNS-RNotice of Investor Presentation
3rd Apr 20253:51 pmRNSDirector/PDMR Shareholding
2nd Apr 20254:33 pmRNSResults of GM, Grant of Awards, PDMR Notifications
2nd Apr 202512:55 pmRNSAppointment of Non-Executive Director
2nd Apr 20257:00 amRNSFinal Results
19th Mar 20257:00 amRNSNotice of Full Year Results
17th Mar 20253:00 pmRNSShareholder Circular & Notice of General Meeting
21st Jan 20257:00 amRNSTrading Update
4th Dec 202412:00 pmRNSDirector/PDMR Shareholding
9th Oct 20244:00 pmRNSCancellation of Long-Term Incentive Plan
3rd Oct 20243:00 pmRNSDirector / PDMR Dealing
1st Oct 202411:00 amRNSDirector / PDMR Dealing
18th Sep 20247:01 amRNSAppointment of Non-Executive Director
18th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
14th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
9th Jul 20247:00 amRNSHalf year trading update
19th Jun 20245:34 pmRNSResult of AGM
6th Jun 20247:00 amRNSInvestor Presentation of FY 2023 Results
4th Jun 20247:00 amRNSAGFX secures Australian Financial Services License
17th May 20243:30 pmRNSHolding(s) in Company
13th May 20246:20 pmRNSDirector/PDMR Dealings
13th May 20241:45 pmRNSPublication of Annual Report and Notice of AGM
9th May 20246:00 pmRNSResult of Placing and Retail Offer
9th May 202410:40 amRNSDirector / PDMR Dealing
3rd May 20247:00 amRNSRetail Offer
2nd May 20245:55 pmRNSResults of Placing
2nd May 20247:01 amRNSProposed Fundraise
2nd May 20247:00 amRNSFull Year Results For the Year Ended 31/12/2023
17th Apr 20247:00 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSHolding(s) in Company
14th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSTrading Update and CFO appointment
23rd Nov 20237:00 amRNSDirector/PDMR Dealing
21st Nov 20234:12 pmRNSDirector/PDMR Dealing
16th Nov 20239:23 amRNSAppointment of Non-executive Director
10th Nov 20237:00 amRNSTrading Statement
9th Nov 20233:18 pmRNSStandard form for notification of major holdings
9th Nov 20237:00 amRNSBoard Change
6th Nov 20239:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.